معرفی
Charlotte Welinder is a Principal Investigator and Mass Spectrometry Researcher affiliated with Lund University Cancer Centre (LUCC) at Lund University. She serves as a BioMS Principal Investigator and conducts research primarily in cancer proteomics and biomarker discovery.
Her research expertise spans across several domains of cancer biology and proteomics, with a particular focus on melanoma. Her work contributes to the UN Sustainable Development Goals related to health and well-being.
Dr. Welinder's research interests include:
- Cancer Proteomics and Biomarker Discovery
- Melanoma Biology and Therapeutics
- Mass Spectrometry Method Development
- Protein Biochemistry and Glycoproteomics
- Translational Medicine Applications
Her recent publications demonstrate a strong focus on applying proteomic approaches to understand cancer biology, particularly melanoma, as well as applications in other disease areas including lupus, tuberculosis, and neurological disorders. Her work often involves collaboration across multiple institutions and integrates various omics approaches.
Scientific Awards:
- Best Poster Award (2023)
Dr. Welinder has supervised research work, as indicated by the 'Supervised Work (1)' section in her profile. Her research is supported by collaborations across multiple institutions as shown in her network analysis, with recent external collaborations spanning multiple countries.
She is associated with the BioMS facility at Lund University Cancer Centre, which likely serves as her primary research laboratory for mass spectrometry-based proteomic analyses.
